Lineage Cell (Israel) Probability of Future Stock Price Finishing Over 561.44
| BTX Stock | ILS 418.00 29.30 6.55% |
Lineage |
Lineage Cell Target Price Odds to finish over 561.44
The tendency of Lineage Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over S 561.44 or more in 90 days |
| 418.00 | 90 days | 561.44 | near 1 |
Based on a normal probability distribution, the odds of Lineage Cell to move over S 561.44 or more in 90 days from now is near 1 (This Lineage Cell Therapeutics probability density function shows the probability of Lineage Stock to fall within a particular range of prices over 90 days) . Probability of Lineage Cell Therapeutics price to stay between its current price of S 418.00 and S 561.44 at the end of the 90-day period is about 61.6 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.23 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Lineage Cell will likely underperform. Additionally Lineage Cell Therapeutics has an alpha of 0.2236, implying that it can generate a 0.22 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Lineage Cell Price Density |
| Price |
Predictive Modules for Lineage Cell
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lineage Cell Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lineage Cell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lineage Cell Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lineage Cell is not an exception. The market had few large corrections towards the Lineage Cell's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lineage Cell Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lineage Cell within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.22 | |
β | Beta against NYSE Composite | 1.23 | |
σ | Overall volatility | 48.05 | |
Ir | Information ratio | 0.04 |
Lineage Cell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lineage Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lineage Cell Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lineage Cell had very high historical volatility over the last 90 days | |
| The company reported the revenue of 4.99 M. Net Loss for the year was (45.99 M) with profit before overhead, payroll, taxes, and interest of 4.69 M. | |
| Lineage Cell Therapeutics has accumulated about 27.1 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. |
Lineage Cell Technical Analysis
Lineage Cell's future price can be derived by breaking down and analyzing its technical indicators over time. Lineage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lineage Cell Therapeutics. In general, you should focus on analyzing Lineage Stock price patterns and their correlations with different microeconomic environments and drivers.
Lineage Cell Predictive Forecast Models
Lineage Cell's time-series forecasting models is one of many Lineage Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lineage Cell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lineage Cell Therapeutics
Checking the ongoing alerts about Lineage Cell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lineage Cell Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lineage Cell had very high historical volatility over the last 90 days | |
| The company reported the revenue of 4.99 M. Net Loss for the year was (45.99 M) with profit before overhead, payroll, taxes, and interest of 4.69 M. | |
| Lineage Cell Therapeutics has accumulated about 27.1 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. |
Check out Lineage Cell Backtesting, Lineage Cell Valuation, Lineage Cell Correlation, Lineage Cell Hype Analysis, Lineage Cell Volatility, Lineage Cell History as well as Lineage Cell Performance. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Lineage Stock analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |